CEF27,Epstein-Barr Virus BRLF-1 lytic 148-156
CAS No. 254110-79-7
CEF27,Epstein-Barr Virus BRLF-1 lytic 148-156 ( —— )
产品货号. M29966 CAS No. 254110-79-7
HLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
生物学信息
-
产品名称CEF27,Epstein-Barr Virus BRLF-1 lytic 148-156
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述HLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).
-
产品描述HLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).(In Vitro):Expression of the EBV immediate-early (IE) protein BRLF1 induces the lytic form of viral replication in most EBV-positive cell lines.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number254110-79-7
-
分子量302.9
-
分子式TKSVY2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称Sequence:{Arg}{Val}{Arg}{Ala}{Tyr}{Thr}{Tyr}{Ser}{Lys}
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
Darr CD, et al. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation. J Virol. 2001 Jul;75(13):6135-42.
产品手册
关联产品
-
Ginsenoside Rh1
Ginsenoside Rg1, one of the main constituents of Panax ginseng, exhibits anti-inflammatory effect.
-
LQZ-7I
LQZ-7I is an inhibitor of surviving-targeting. It orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors.
-
Poricoic acid AM
Poricoic acid AM is a triterpenoid compound extracted from Poria cocos, demonstrating anti-tumor activity.